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Parasitic infections cause a myriad of responses in their mammalian hosts, on immune as well as on
metabolic level. A multiplex panel of cytokines and metabolites derived from four parasite-rodent models,
namely, Plasmodiumberghei-mouse, Trypanosoma brucei brucei-mouse,Schistosomamansoni-mouse,
and Fasciola hepatica-rat were statistically coanalyzed. 1H NMR spectroscopy and multivariate statistical
analysis were used to characterize the urine and plasma metabolite profiles in infected and noninfected
animals. Each parasite generated a uniquemetabolic signature in the host. Plasma cytokine concentrations
were obtained using the ‘Meso Scale Discovery’ multi cytokine assay platform.Multivariate data integration
methodswere subsequently used to elucidate the component of themetabolic signaturewhich is associated
with inflammation and to determine specificmetabolic correlates with parasite-induced changes in plasma
cytokine levels. For example, the relative levels of acetyl glycoproteins extracted from the plasmametabolite
profile in the P. berghei-infected mice were statistically correlated with IFN-γ, whereas the same cytokine
was anticorrelated with glucose levels. Both the metabolic and the cytokine data showed a similar spatial
distribution in principal component analysis scores plots constructed for the combined murine data, with
samples from all infected animals clustering according to the parasite species and whereby the protozoan
infections (P. berghei and T. b. brucei) grouped separately from the helminth infection (S. mansoni). For
S.mansoni, themain infection-responsive cytokines were IL-4 and IL-5, which covariedwith lactate, choline,
and D-3-hydroxybutyrate. This study demonstrates that the inherently differential immune response to single-
and multicellular parasites not only manifests in the cytokine expression, but also consequently imprints
on the metabolic signature, and calls for in-depth analysis to further explore direct links between immune
features and biochemical pathways.
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Introduction
Parasitic infections induce a variety of biochemical responses
in the host, including modulation of energy metabolism,1-3
inflammation,4-6 anemia,7-9 and nutrient deficiencies.10-12
The effective control and eventual elimination of these invading
organisms is generally mediated by both cellular and humoral
immune mechanisms, and includes different T cell-effector
mechanisms, such as those reflected by the increase in Th1,
Th17, Th2 subtype CD4+ cells, as well as regulatory T-cells.13-19
The Th1/Th2 paradigm originally postulated by Mosmann and
Coffman in 1986 described a framework for understanding
immunological control mechanisms,20 which were simplified
into two main mechanisms: Th1 or ‘cell-mediated’ immunity
and Th2 or ‘humoral’ immunity. Intracellular parasites (e.g.,
bacteria and protozoa) are effectively fought by a Th1 response
and the promotion of direct cytotoxic activity, which, in turn,
can lead to tissue damage in the host.6,19 Helminth infections,
in contrast, are controlled by Th2-based immune mechanisms,
which involve secretion of antibodies, promotion of eosino-
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philia (IL-5),21 production of IgE and IgG1 (IL-4), mastocytosis,
and mediation of helminth expulsion.22,23
However, this original Th1/Th2 dogma is somewhat over-
simplified and it is necessary to consider emerging evidence
of other immunological processes. For example, Th17 subtype
CD4+ cells, which are reported to control microparasites
effectively (e.g., bacteria and fungi) also promote certain
autoimmune mechanisms,17,24,25 whereas T-regulatory cells
(Tregs) are activated in an exclusive fashion to Th17 cells and
fine-tune the immune-response of the host.14-16
The immune outcome and the associated cytokine profile
manifested by the host in response to parasitic infection are
dependent upon the parasitic species, intensity of infection,
the first organ of antigen exposure and also the cytokine milieu
already present within the host.26
In addition to immunologic changes, parasitic infections
cause direct cellular events such as altered energy metabolism.
Metabolic profiling strategies combining spectroscopic finger-
printing with mathematical modeling have previously been
applied to characterize the global response of the host at the
metabolic level and have been discussed in the light of specific
measured inflammatory components in particular disease
conditions, such as breast cancer27 and colitis,28 but thus far
metabolic signatures of pathology have not been systematically
modeled with immunological profiles.
Several single-parasite infection models have been investi-
gated in rodents, using 1H nuclear magnetic resonance (NMR)
spectroscopy to generate biochemical signatures of various
biological fluids and tissues. These studies have defined panels
of metabolic biomarkers reflective of the various components
of the biological response to specific parasites. In addition to
biochemical changes induced as a direct consequence of tissue
pathology, some components of these metabolic responses are
likely to be directly linked to immunologic events, in particular
the inflammatory response. For example, a Trypanosoma brucei
brucei infection in the mouse has been associated with
increased circulating levels of acetylated glycoproteins,29 which
are normally secreted in the liver in response to pro-inflam-
matory cytokines. Conversely, increased plasma levels of lactate
and depleted glucose have also been documented to be a
feature of a T. b. brucei infection in the mouse and imply
increased glycolytic activity in the parasite independent of the
inflammation.29
Here, we assess covariance between immunological param-
eters as defined by the pattern of multiple cytokines, and the
metabolic phenotypes, as defined by the 1H NMR spectral
profiles, in biofluids obtained from four parasite-rodent
models. We propose a new strategy for correlating the plasma
concentrations of several selected Th1/Th2 cytokines with the
biochemical signature of the different parasite-rodent models,
including protozoan (Th1-inducing) and helminth (Th2-induc-
ing) infections and elucidate model-dependent and model-
independent associations of inflammatory measures with
metabolic phenotypes with a view to highlighting the compo-
nent of the metabolic signature, which is associated with, or
modulated by, parasite-specific host inflammatory responses.
Methods
The levels of selected plasma cytokines were coanalyzed with
pre-existingspectroscopicdatafromfourdifferentparasite-rodent
models.
Animal Husbandry and Sample Collection. All animal
experiments were carried out at the Swiss Tropical Institute
(Basel, Switzerland) and complied with Swiss local and national
regulations on animal welfare (permission no. 2081). Three
separate batches of NMRI female mice were purchased from
RCC (Itingen, Switzerland). Animals were kept under environ-
mentally controlled conditions (light/dark cycle, 12/12 h;
temperature, ∼22 °C; relative humidity, 60-70%) with unre-
stricted access to community tap water and standard rodent
diet (NAFAG; Gossau, Switzerland). Animals were acclima-
tized for 1-2 weeks prior to the onset of each experiment.
Sample collection in the Plasmodium berghei-mouse,
T. b. brucei-mouse and Schistosoma mansoni-mouse models
have been described elsewhere.,2,3,30 In brief, urine samples
were collected into a Petri dish by gently rubing the abdomen
until a minimum volume of 20 µL was obtained. Whole blood
was collected from the tail tip of the mice using sodium
heparin-coated hematocrit capillaries. The plasma was sepa-
rated from the cellular components by centrifuging the whole
blood sample at 4,000 g for 4 min. Both urine and plasma
samples were transferred into Eppendorf tubes on dry ice
immediately after collection prior to storage at -40 °C.
Additionally, a Fasciola hepatica-rat model was included,
which allowed subsequent comparison between results ob-
tained from mice and rats. The experimental details from each
of the parasite-rodent models are summarized in Table 1 and
a reference provided to indicate the rationale for selection of
the infection intensities and sampling time points for each
model.31-34
For the cytokine analysis, 5 infected and 5 noninfected control
animals were analyzed for the T. b. brucei-mousemodel (28 days
postinfection), and 5 infected and 4 noninfected control animals
for the F. hepatica-rat model (22 days postinfection). In the case
of S. mansoni-mouse (53 days postinfection), 7 infected and 5
noninfected animals were used due to the observed variation
in metabolic profiles in the infected group. Since the duration
of the P. berghei model was only 4 days, an age-matched
control group was deemed unnecessary, particularly in view
of the 3R rules (reduce, replace, and refine), and hence the
postinfection samples group (day 4) was directly compared with
the preinfection samples group.
1H NMR Spectroscopy of Urine and Plasma Samples. Urine
and plasma samples were analyzed using standard one-
dimensional (1D) 1H NMR spectroscopy at 600 MHz with
suppression of the water signal, according to a published
protocol.30
Quantitative Cytokine Level Measurement in Plasma
Samples. Cytokine measurements were made using the ‘Meso
Scale Discovery’ (MSD)-based multi cytokine approach.34 The
commercial mouse-specific 96-well multispot plate of Th1/Th2
cytokines (TNF-R, mKC, IL-5, IL-4, IL-2, IL-1, IL-12, IL-10, and
IFN-γ) was used for the murine models and the corresponding
rat demonstration kit (IFN-γ, IL-1, IL-4, IL-5, IL-13, KC/GRO,
and TNF-R) was selected for the F. hepatica-rat model. The
concentrations of cytokines were quantified using an 8-point
calibration curve constructed from a plot of the signal intensity
for a series of known concentrations of the multiplex standard
provided by the kit manufacturer. The data were analyzed using
MSDWorkbench software and the curves fitted using the built-
in 4PL fit with 1/y2 weighting (y ) b2 + ((b1 - b2)/(1 + (x/
b3)b4)). Validation of the MSD platform and comparison with
Luminex, a different multiplex technology has been conducted
previously.35
Each plasma sample was measured in duplicate and an
aliquot of 20 µL placed into separate wells. The measurement
research articles Saric et al.
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procedure was performed according to the manufacturer’s
protocol with the exception that the incubation time used was
4 h. Plasma samples from all selected animals were obtained
after nondestructive 1H NMR spectral acquisition (e.g., a 1:1
dilution in saline, containing 90% deuterated water, was
implemented); hence, the incubation time was extended from
2 to 4 h in order to compensate for the dilution factor and to
increase the sensitivity of the assay. A MSD Sector Imager
(Sector Imager 6000; Gaithersburg, MD) was utilized to read
the plates.
Multivariate Statistical Data Analysis. Principal component
analysis (PCA) was applied to each individual parasite-host
data set and also to the combined murine data for S. mansoni,
P. berghei, and T. b. brucei infections. Since PCA is an
unsupervised method and makes no assumption as to the
origin or class of samples, it allows the major sources of
variance in a data set to be defined without incorporating
inherent bias. Application to a complex matrix, such as those
represented here by the NMR spectral data or the cytokine data
(X-matrix), achieves a reduction in the dimensionality of the
data matrix, identifies outliers and facilitates visualization of
the data distribution.36,37
To maximize the variance in the NMR data related to the
response to the infection, supervised multivariate methods
were also applied. Projection to latent structure discriminant
analysis (PLS-DA) was conducted on both the NMR data and
the cytokine data separately, using a binary code to indicate
infection or noninfection as the Y-matrix. The information on
class membership allows optimal extraction of the particular
observations (e.g., metabolites), which are responsible for the
differentiation of groups and can maximize separation in the
PLS-DA model. However, PLS-DA can also include variation
that is not response class or Y-related. By incorporation of an
orthogonal filter (O-PLS), systematic variation unrelated to
infection status can be removed and thereby facilitates the
interpretation of infection-related effects.38 Here, an in-house
adapted O-PLS script was used39 to perform a cross-matrix
correlation between 1H NMR-derived spectral information (X)
and identity matched single cytokine levels (Y) in order to find
connections between metabolic and immune metrics.
Results
Physiological Monitoring of Rodents over the Course of
Infection. The establishment of infection in the 4 parasite-
rodent models employed was verified by hematologic para-
meters and histological examination. Worm counts upon
dissection were also used in the case of helminths. All parasitic
infections induced clear pathology in all infected animals as
described in Table 1, with the exception of the S.
mansoni-mouse model, where the establishment of infection
could not be confirmed for 2 out of 7 infected mice. Images of
hematoxylin and eosin stained selected sections of host organs
are provided for each of the four infection models in Figure 1,
showing pathological events in spleen tissue sections from P.
berghei (Figure 1A) and S. mansoni-infected mice (Figure 1C)
and in liver sections from F. hepatica-infected rats (Figure 1B),
and T. b. brucei-infected mice (Figure 1D). Pathological changes
were also observed in the kidney of T. b. brucei-infected mice,30
which showed interstitial nephritis and F. hepatica-infected rats
demonstrated splenic follicular hyperplasia with inflammatory
infiltrates found in the kidney (unpublished data) (Table 1).
Metabolic Characterization of Parasite Effects in Rodent
Models. The parasite-infected animals were easily differentiated
from noninfected controls using PCA and O-PLS-DA models
and the disease-related biological markers were extracted from
urinary and plasma metabolite profiles.
Metabolic characterization of the T. b. brucei-mouse,30 and
P. berghei-mouse3 models has been conducted and described
previously. In brief, the infection with both protozoan parasites
induced depleted plasma glucose concentrations and subse-
quently increased lactate levels, reflecting a higher glycolytic
activity postinfection. Increased levels of O-acetyl glycoproteins
were found in the plasma of T. b. brucei, but not P. berghei-
Table 1. Infection Parameters of the 4 Parasite-Rodent Models Employed
a No. animals: (C), non-infected animals; (T), infected animals; and (P), pre-infection; v increased upon infection, V decreased upon infection. Altered
Cytokines: Top 4 cytokines that co-map with the infection in the PCA analysis. *Specific for mouse and **Specific for rat multi-cytokine panel.
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infected mice. The urinary manifestation of both protozoan
species shared some similarities, including an increase in
2-oxoisovalerate levels, but also elicited disease specific mark-
ers, such as increased pipecolic acid (P. berghei) and increased
4-hydroxyphenyl acetic acid (T. b. brucei).
F. hepatica induced systematic changes in the plasma
metabolite profile as illustrated in the O-PLS-DA coefficient plot
(Figure 2A). F. hepatica infection caused a decrease in plasma
levels of TMAO, and increased relative levels of the O- and
N-acetyl glycoproteins (Figure 2A), with a concomitant deple-
tion of urinary creatinine and taurine. A relative increase in
the concentration of bile acids was also evident. The scores
from both the O-PLS-DA and the PCAmodels constructed from
the plasma 1H NMR spectral data of F. hepatica-infected rats
on day 22 postinfection, when overt pathology was established,
demonstrated discrete clustering of 1H NMR plasma spectra
relating to control and infected rats (Figure 2B) (O-PLS-DA: R2Y
) 0.90, Q2Y ) 0.57; PCA: R2cumX ) 0.96, Q2X ) 0.40). One O-PLS
component and one orthogonal component were used for the
O-PLS-DA model, whereas for the PCA analysis three principal
components (PCs) were used to construct the model.
Global PCA and PLS-DA analyses on the combined spectral
data sets derived from the three murine models showed that
the samples from the protozoan infections were biochemically
distinct from samples from S. mansoni-infected mice, which
formed a separate cluster along the axis of the third PC (Figure
3A and Supporting Information). The PLS-DA model was
constructed using three PCs (PLS-DA: R2X ) 0.40, R2Y ) 0.71,
Q2Y ) 0.33). From the scores and the corresponding loadings,
it was apparent that the biochemical composition of the control
samples relating to each parasite-host model differed accord-
ing to batch, particularly with respect to T. b. brucei. These
observed batch differences are unsurprising given that an
outbred mouse strain was used as the host. Furthermore, age-
dependent variation might contribute to the differences within
the control groups; all control animals were approximately the
same age prior to the infection, but due to the different length
of time required to establish a patent infection, the time of
sampling ranged from 4 days postinfection in the shortest
model (P. berghei) to 53 days postinfection in the longest
(S. mansoni). However, despite the interbatch variation, it was
obvious that the S. mansoni infection drove the metabolite
profiles in a different direction to the two protozoan infections
and that the batch differences could be largely eliminated by
use of O-PLS modeling (data not shown).
The recovery of urine and plasma metabolic candidate
biomarkers (1D standard pulse program) for S. mansoni via
O-PLS-DA comprised higher levels of urinary phenylacetylg-
lycine and 3-ureidopropanoate, and lower relative levels of
2-oxoisocaproate, hippurate and 2-oxoiadipate, while the
plasma profile was characterized by lower concentrations of
acetate, glucose and citrate, but relatively higher lipoprotein
fractions (Table 1). The spectral PCA scores plot of plasma
samples from S. mansoni-infected and noninfected mice
showed three separate groupings (Figure 4A), whereby in
addition to clear separation of infected and noninfected
animals, a third cluster was evident, consisting of two individual
mice that underwent initial infection but where infection failed
to establish, as evidenced by zero worm counts upon dissection
of these mice. The PLS-DA model was built using two com-
ponents (PLS-DA: R2X ) 0.32, R2Y ) 0.83, Q2Y ) 0.20).
Characterization of the Immune Response to Parasite
Infection Using Multiplex Cytokine Assays. Separate PLS-DA
models were constructed comparing infected and noninfected
Figure 1. (A) Reactive follicular hyperplasia detected in a mouse spleen 4 days after infection with P. berghei. Large germinal centers
are shown, formed of immune- and centroblasts. Red pulp congestion was further indicated by abundant hemozoin in cordal
macrophages; (B) liver tissue sections from a F. hepatica-infected rat showing typical cavity-like necrotic tunnels that were demarked
by a foreign body reaction (100×); (C) lymphofollicular hyperplasia was detected in the spleen of S. mansoni-infected mice and indicated
by prominent germinal centers including tangible body macrophages; (D) hepatic hemopoiesis after infection with T. b. brucei.
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control animals for each parasite-rodent model, or in the case
of P. berghei, pre- and postinfection status. The top 4 discrimi-
nating variables (i.e., cytokines) were extracted. For P. berghei
infection, IL-12, mKC, IFN-γ, and IL-4 were the 4 most
discriminatory cytokines between the pre- and postinfection
time points, whereas the T. b. brucei-infected mice were
discriminated from the controls at day 28 postinfection mainly
by IL-1 and IL-5. The main discriminatory cytokines for each
pairwise comparison of infection and noninfection status
investigated are listed in Table 1. The cytokine distribution of
rats infected with F. hepatica was also clearly differentiated
from that of controls as shown in the PCA scores and loadings
plots (Figures 2C,D), whereby separation was mainly influenced
by increased IL-5 levels in infected animals (R2cumX ) 0.99, Q2X
) 0.71). Three PCs were used to build the model. Similarly to
the analysis of the metabolic data, PCA analysis of cytokine
data of the S. mansoni-infection model indicated the presence
of three different groups, one of which corresponded to the
two animals in the infected group in which infection failed to
establish (Figures 4C,D) (R2cumX ) 0.67, Q2X ) 0.25). The model
was constructed using 2 PCs. Samples from these animals were
clearly separated from both uninfected controls and the
infected mice, and the mapping position from these anomalous
mice was mainly influenced by the plasma level of mKC, which
was relatively higher in these two mice than in either the
infected or the noninfected control animals (Figures 4C,D).
To compare plasma levels of the cytokines across the
different parasitic infections in the same host species (i.e.,
NMRI mouse), PCA analyses were carried out on the integrated
murine data set using two PCs (R2cumX ) 0.67, Q2X ) 0.18). The
distribution of the samples in a multivariate space was com-
pared for the three murine infection models based on the
cytokine composition (Figure 3C,D), as determined via the PCA
scores and loadings plots (S. mansoni on day 53 postinfection,
T. b. brucei on day 28 postinfection, P. berghei on day 4
postinfection). The two protozoan infections demonstrated a
similar trend in mapping position in the plots and deviated
from the control group in the first PC, but T. b. brucei-infected
mice had a wider spread compared to the animals infected with
P. berghei, indicating greater variation in response to infection.
In contrast, the trematode S. mansoni induced an orthogonal
shift in the second PC direction compared to the two protozoan
infections, with a marked discrimination from the controls also
along the second PC axis. Higher levels of IL-4 and IL-5
dominated the separation between S. mansoni-infected animals
from both protozoan infected and noninfected control mice.
Increased concentrations of IL-12, TNF-R, IL-10, IFN-γ, and
IL-2 were the main contributors to the discrimination of the
mice infected with protozoa.
Inter-Matrix Data Correlation of Relative Cytokine Levels
and 1H NMR Spectral Intensities. The matrices for both the
NMR-characterized metabolite profiles and the cytokine data
were statistically related using O-PLS analysis in order to obtain
information on potentially causal events at the interface of the
metabolic and immune systems. The model was constructed
using one PLS component and one orthogonal component (O-
PLS-DA: R2Y) 0.99, Q2Y) 0.77). There were several statistically
significant correlations between the relative cytokine levels and
the corresponding plasma spectra of 5 mice preinfection and
at days 2 and 4 postinfection in mice infected with P. berghei
(Figure 5). A positive correlation was found between IFN-γ and
plasma concentrations of N-acetyl glycoprotein fragments,
lactate, creatine, and glycine, whereas IFN-γ was anticorrelated
with glucose. The same correlation script was applied to urine
and plasma spectra from each of the parasite-host models.
Although trends in covariation between metabolites and cy-
Figure 2. Differentiation of plasma samples obtained from a pairwise comparison of plasma 1H NMR data of F. hepatica-infected vs.
noninfected control rats at day 22 postinfection. (A) O-PLS-DA coefficient plot; (B) PCA of 1H NMR plasma data; (C) PCA scores plot;
and (D) PCA coefficients plot based on the relative levels of selected cytokines assessed on day 22 postinfection in F. hepatica-infected
rats (orange) and noninfected control rats (black).
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tokines were established, the correlations between the relative
cytokine levels and metabolites were not significant, which may
be due to the relatively small group sizes.
Discussion
Each of the assessed parasite-rodent models gave rise to a
distinct pathological phenotype on the basis of both the
metabolic and immunologic profiles.
Metabolic Phenotype Description of Parasite-Host Models.
The metabolic fingerprint of each infection was composed of
disease-specific features such as relatively increased urinary
levels of pipecolic acid due to a P. berghei infection, or
increased 4-hydroxyphenylacetic acid as response to a
T. b. brucei infection (Table 1). On the other hand, several
biomarkers were indicative of more than one infection, sug-
gesting some commonly affected metabolic pathways across
infections. Interestingly, many of the gut microbial-derived
urinary metabolites seem to undergo similar directional changes
in response to parasite infection, such as depleted concentra-
tions of hippurate (T. b. brucei, S. mansoni, and F. hepatica),
increased trimethylamine (T. b. brucei and S. mansoni) and
increased phenylacetylglycine (P. berghei and S. mansoni). The
association of hippurate, phenylacetylglycine, and the oxidized
form of trimethylamine (TMAO) with gut microbial composi-
tion and/or activity has been underlined by studies on germ-
free rats and mice with a reduced microbial composition.40,41
The involvement of the gut microbiota has been discussed in
more detail previously with regard to parasite infections.2,3,30
A common metabolic feature between T. b. brucei and
F. hepatica was the elevation in levels of acetylated glycopro-
teins in plasma (both N- and O-acetyl glycoproteins). Acute
phase proteins, such as transferrin, R-1-antitrypsin or hapto-
globin, are secreted by hepatocytes in response to tissue
damage and act as inflammatory mediators,42,43 and thus, the
increased concentrations of plasma acetylated glycoproteins
are likely to reflect an inflammatory response.
Further analysis of S. mansoni-infected, noninfected control
mice and the intermediate which group of 2 mice, which
underwent experimental infection but which failed to establish
adult worms, showed a comapping of the branched chain
amino acids (BCAAs) with the established infection group,
whereas the phenylacetylglycine, tyrosine and trimethylamine
contributed most to the separation of the “intermediate” group,
which may suggest an involvement of the gut microbial
environment in susceptibility and resistance to a helminth
infection and merits further investigation.
Comparison of the metabolic profiles of plasma across the
three mouse models showed a spatial separation of the
helminth infection from the two protozoan infections along
the third PC. The corresponding loadings revealed relatively
higher levels of lactate, acetate and creatine in the protozoan
infections, whereas the (CH2)n-lipid signals were relatively
lower.
Parasite Specific Differences in Cytokine Profiles. The
cytokine modulations induced by each parasite were largely
consistent with the literature.6,44,45 The differentiation of
Figure 3. Global PLS-DA scores (A) and loadings line plots for discriminatory components 2 and 3 (B) from plasma 1H NMR spectral
data showing differentiation of the samples from noninfected control animals (black) and the 3 parasite-mouse models; S. mansoni
(red), T. b. brucei (green), and P. berghei (blue). The protozoan infections are clearly differentiated from the noninfected and S. mansoni-
infected groups along the first PC, while S. mansoni is differentiated from all other groups in the second PC. (C) PCA scores plot and
(D) loadings plots derived from relative cytokine levels from matched animals from each infection model.
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F. hepatica-infected from noninfected control rats was domi-
nated by increased plasma IL-13, IL-5, and IL-1 levels (Table
1). IL-13, characteristically a Th2 cytokine, has been shown to
directly inhibit pro-inflammatory cytokines in macrophages
and plays an important role in minimizing the hepatic inflam-
mation caused by the migrating larvae of F. hepatica. The
cytokine response to the extracellular protozoan parasite
T. b. brucei consisted of mixed Th-subset mechanisms reflecting
both cell-mediated and humoral immune mechanisms. The
main differential markers of infection with P. berghei, IL-12,
Figure 4. (A) PLS-DA scores plot showing plasma metabolite-based differentiation of S. mansoni-infected (red), noninfected control
animals (black) and mice, which did not establish infection (possibly demonstrating early expulsion) as assessed upon dissection
(blue), and (B) loadings line plot for the first and second PCs. (C) PCA scores plot of the relative plasma cytokine concentrations, and
(D) main corresponding loadings showing similar infection-related clustering as the spectral data; (E) bar chart showing plasma cytokine
concentrations for S. mansoni-infected mice. Values are mean ( standard deviation. Significance determined by Student’s t-test (2-
tailed, unpaired) p ) * <0.05, ** <0.01, *** <0.001 (since there were only two animals in which infection failed to establish, statistical
significance was not determined for the intermediate group). Note: Cytokine concentrations have been scaled to allow visual comparison
across cytokines. IL-4 scaled 1:2, IL-5 scaled 1:10, IL-12 scaled 1:50 and mKC scaled 1:200. *No significance given for mKC for S. mansoni-
absence since n ) 2.
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and IFN-γ, are typical Th1 cytokines, whereas S. mansoni
induced a Th2-dominated cytokine pattern (e.g.,
IL-4 and IL-5). As observed with the metabolic profiles, the S.
mansoni-infected mice were further divided into two subgroups
corresponding to 5 mice where infection was established as
confirmed by worm counts in the liver and mesenteric veins46
and 2 mice where infection failed to establish (intermediate
group). The driving cytokine component in the intermediate
group was mKC, whereas the main descriptors for established
infection were the Th2 cytokines IL-4, IL-5, and IL-10. Although,
the most effective response to a worm infection is believed to
be Th2-based, S. mansoni seems more efficiently controlled
by an initial strong cell-mediated (Th1) mechanism, which
transfers to a Th2-mediated response with progressing course
of disease in order to counteract the chronic inflammation
caused by the eggs in the liver and other tissues.45,47 The mouse
functional analogue of human IL-8, mKC, has been shown to
play a major role in acute inflammation by recruiting and
activating neutrophils to the sites of inflammation,48,49 which
raises the question if those functions would be crucial to the
expulsion of S. mansoni in particular.
Direct comparison of the plasma cytokine profiles from
S. mansoni with those from both protozoan infections in a PCA
analysis (Figure 3C) showed clustering of all corresponding
control animals and separation of the three infected groups,
wherein the 2 groups of mice infected by the protozoan
parasites were differentiated from the controls in the first PC
and from the trematode infection in the second component.
However, the two protozoan infections could also be differenti-
ated from each other with respect to the infection-induced
alterations in host cytokine levels.
It is widely established that helminth infections induce a
strong Th2-mediated immune response and here the S.
mansoni-induced cytokine expression at a chronic stage time
point was consistent with Th2-dominated immune mecha-
nisms. The Th1 subset of cytokines involved in the response
to T. b. brucei and P. berghei, on the other hand, was
stronger, as suggested by increased IL-12 and IFN-γ, which
are ranked higher in the list of the discriminatory cytokines
in the protozoan infections, particularly with respect to P.
berghei. Many protozoan parasites have intracellular stages
where they are cleared by cell-mediated immune mecha-
nisms induced by the Th1 cytokine subset.6,26 Even though
T. b. brucei is an extracellular parasite like S. mansoni, its
effect on the host immune system is closer to that of P.
berghei, which manifests both intra- and extracellular stages.
African trypanosome species trigger a strong cellular immune
response (Th1-mediated) in infected mice via their variant
surface glycoproteins (VSGs), which cover the parasite coat, and
for which constant remodeling contributes to successful eva-
sion from the humoral immunity.50 The relatively lower plasma
levels of triglycerides (VLDL/LDL) and phosphatidylcholine
observed following a T. b. brucei infection, with subsequent
increase of choline in the plasma of T. b. brucei-infected mice
may be associated with the constant remodeling of the glyco-
sylphosphatidylinositol (GPI) anchor of T. b. brucei, in order
to enable the rapidly changing VSG composition. VSGs also
induce secretion of TNF-R, which initiates B-cell proliferation
and has a direct cytotoxic effect on T. b. brucei.51
Covariance between Metabolic and Cytokine Data. To
obtain an overview of the global similarities/dissimilarities
between the different infection-induced signatures of the 3
parasite-mouse models, comparison of the plasma (Figure 3)
and urine samples (data not shown) was made. Both the
metabolic and the cytokine data yielded a similar distribution
of samples (Figure 3), in that samples of the protozoan
infections were differentiated both from the control and from
the helminth infection samples. A tight clustering of the
cytokine data from all control samples was noted in the scores
plot generated from the cytokine data. However, with respect
to the metabolic data, batch differences between the control
samples in both the urine (data not shown) and the plasma
data sets were evident. This is unsurprising given that the NMRI
mouse is an outbred strain and the 1H NMR metabolic profiles
Figure 5. O-PLS correlation analysis of plasma obtained from P. berghei-infected mice (n ) 5) before infection and on days 2 and 4
postinfection correlated with the individual matched relative levels of IFN-γ. Upward-oriented peaks represent positive correlation of
metabolites with IFN-γ concentration and vice versa. a.u. denotes arbitrary unit.
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are composed of thousands of signals, which contribute to the
model and which all have the potential to exhibit batch
variation, whereas the cytokine panel represents a relatively
coarse profile consisting of only 9 variables. Temporal and
batch differences in 1H NMR spectra of biofluids are well
documented and result from the high sensitivity of the
technology.52,53 However, despite the observed batch-to-batch
variation between the 3 parasite-mouse models, the parasite-
induced alteration in the metabolic signature was stronger and
the presence of these batch differences did not impede detec-
tion of clear infection-induced responses with further dif-
ferentiation of the protozoan and helminth infections.
Analysis of each parasite-rodent model uncovered covaria-
tion between a range of metabolic and immune features, which
may potentially be mechanistically related. In the correlation
assessment of plasma 1H NMR spectral data and cytokine
concentrations in the P. berghei data set, direct statistical
connections with biological coherence were evident, such as
the positive correlations of IFN-γ, with N-acetyl glycoproteins,
whereby both are important pro-inflammatory signaling
molecules.
On the other hand, the positive correlation of IFN-γ with
lactate and subsequent negative correlation with glucose
deriving from the P. berghei-induced increase in the glycolytic
activity may simply reflect the fact that these changes domi-
nated the cytokine and metabolic profiles, respectively, and
thereby the statistical correlation may result from covariation
without necessarily inferring a direct mechanistic link. How-
ever, as all other assessed cytokines did not show any signifi-
cant correlation with either glucose or lactate, a more direct
involvement of the immune system and the components of the
glycolysis may still be implicated.
To explore causality, with respect to the observed covaria-
tion, further studies are required. Focusing on the direct
correlation of metabolic and immune components, this ap-
proach will ultimately allow the extraction of directly related
events at the interface of metabolic and immune system and
provide a mechanistic tool for probing pathology.
Conclusion
The approach employed in the current analysis, based on
the parallel and integrated assessment of the metabolite and
cytokine profiles from experimental infections in rodent mod-
els, enabled the extraction of the component of the metabolic
signature directly and indirectly associated with immune
mechanisms. A deeper understanding of the association be-
tween metabolic and immune events in these well-controlled
laboratory models could open new avenues in understanding
immunoregulatory mechanisms and their functions acting at
a global metabolic level across a wide range of parasitic
infections and diseases.
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